202 related articles for article (PubMed ID: 32141413)
1. Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.
Li QS; Shen BN; Zhang Z; Luo S; Ruan BF
Curr Med Chem; 2021; 28(5):940-962. PubMed ID: 32141413
[TBL] [Abstract][Full Text] [Related]
2. Biological activities of pyrazoline derivatives--a recent development.
Kumar S; Bawa S; Drabu S; Kumar R; Gupta H
Recent Pat Antiinfect Drug Discov; 2009 Nov; 4(3):154-63. PubMed ID: 19545230
[TBL] [Abstract][Full Text] [Related]
3. 4,5-Dihydro-1H-pyrazole: an indispensable scaffold.
Alex JM; Kumar R
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):427-42. PubMed ID: 23808806
[TBL] [Abstract][Full Text] [Related]
4. Pyrazoline Derivatives as Promising MAO-A Targeting Antidepressants: An Update.
Choudhary D; Kaur R; Singh TG; Kumar B
Curr Top Med Chem; 2024; 24(5):401-415. PubMed ID: 38318823
[TBL] [Abstract][Full Text] [Related]
5. Recent advancements in the development of bioactive pyrazoline derivatives.
Nehra B; Rulhania S; Jaswal S; Kumar B; Singh G; Monga V
Eur J Med Chem; 2020 Nov; 205():112666. PubMed ID: 32795767
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro antifungal evaluation of 1,3,5-trisubstituted-2-pyrazoline derivatives.
Deng H; Yu ZY; Shi GY; Chen MJ; Tao K; Hou TP
Chem Biol Drug Des; 2012 Mar; 79(3):279-89. PubMed ID: 22181692
[TBL] [Abstract][Full Text] [Related]
7. Diverse Pharmacological Potential of different Substituted Pyrazole Derivatives.
Asif M; M Almehmadi M; Alsaiari A; Allahyani M
Curr Org Synth; 2023 Oct; ():. PubMed ID: 37861007
[TBL] [Abstract][Full Text] [Related]
8. Pyrazoline Hybrids as Promising Anticancer Agents: An Up-to-Date Overview.
Matiadis D; Sagnou M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752126
[TBL] [Abstract][Full Text] [Related]
9. Steroidal pyrazolines as a promising scaffold in drug discovery.
Bansal R; Singh R
Future Med Chem; 2020 May; 12(10):949-959. PubMed ID: 32319322
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents.
Zhang Y; Wu C; Zhang N; Fan R; Ye Y; Xu J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628906
[TBL] [Abstract][Full Text] [Related]
12. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis.
Wang H; Zheng J; Xu W; Chen C; Wei D; Ni W; Pan Y
Molecules; 2017 Sep; 22(10):. PubMed ID: 28961210
[TBL] [Abstract][Full Text] [Related]
13. Pyrazole Containing Anti-HIV Agents: An Update.
Kumar S; Gupta S; Rani V; Sharma P
Med Chem; 2022; 18(8):831-846. PubMed ID: 34994333
[TBL] [Abstract][Full Text] [Related]
14. Antitumor potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in human bladder cancer cells.
Tessmann JW; Buss J; Begnini KR; Berneira LM; Paula FR; de Pereira CMP; Collares T; Seixas FK
Biomed Pharmacother; 2017 Oct; 94():37-46. PubMed ID: 28750358
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the therapeutic applications of pyrazolines.
Shaaban MR; Mayhoub AS; Farag AM
Expert Opin Ther Pat; 2012 Mar; 22(3):253-91. PubMed ID: 22397588
[TBL] [Abstract][Full Text] [Related]
16. Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids.
Havrylyuk D; Roman O; Lesyk R
Eur J Med Chem; 2016 May; 113():145-66. PubMed ID: 26922234
[TBL] [Abstract][Full Text] [Related]
17. Pyrazoline: a promising scaffold for the inhibition of monoamine oxidase.
Mathew B; Suresh J; Anbazhagan S; Mathew GE
Cent Nerv Syst Agents Med Chem; 2013; 13(3):195-206. PubMed ID: 24533911
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
20. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
